LY-367,265


LY-367,265 is a drug developed by Eli Lilly, which acts as both a potent and selective antagonist at the serotonin 5-HT2A receptor, and also a selective serotonin reuptake inhibitor. It has antidepressant effects in animal studies, reduces glutamate signalling in the brain and increases the analgesic effects of morphine.